Clinical Trial Update: Tolerance and Effectiveness of C14 on HPV Infection [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial update for C14 (Monoterpenoid Zinc Tetra-ascorbo-camphorate) evaluating tolerance and effectiveness against human papillomavirus infe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Hpv-related Cancers
• Human Papillomavirus Infection

Drugs mentioned

• C14 (Monoterpenoid Zinc Tetra-ascorbo-camphorate)

Snippet

Sponsor: MGB Pharma | Conditions: HPV-induced Cancers, HPV Infections | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING